Drug Manufacturers - General Industry | Healthcare Sector | Mr. Robert M. Davis J.D. CEO | XMUN Exchange | DE0006599905 ISIN |
US Country | 70,000 Employees | 16 Sep 2024 Last Dividend | - Last Split | 13 Jan 1978 IPO Date |
Merck & Co., Inc. is a global healthcare leader focused on innovating new solutions to tackle some of the most serious health challenges. Founded in 1891 and headquartered in Rahway, New Jersey, the company operates worldwide, engaging in the discovery, development, manufacturing, and marketing of pharmaceuticals and animal health products. It operates two main segments: Pharmaceutical and Animal Health. The Pharmaceutical segment is dedicated to developing and offering human health pharmaceutical products across a range of areas including oncology, cardiovascular, and diabetes, among others. The Animal Health segment works on veterinary pharmaceuticals, vaccines, and health management solutions and services. Merck serves a diverse clientele, including drug wholesalers, retailers, hospitals, government agencies, physicians, veterinarians, and pet owners. Notably, the company invests in several strategic collaborations and agreements with other pharmaceutical giants like AstraZeneca PLC and Bayer AG, aiming to enhance its product offerings and harness innovative treatments for multiple diseases.
The products and services offered by Merck & Co., Inc. span a broad spectrum of medical needs in both human and animal health sectors:
In the arena of collaborative efforts, Merck has entered into multiple significant agreements to bolster its product pipeline: